OncoCyte Corporation (OCX)
USD 2.2
(-0.45%)
USD 2.2
(-0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.5 Million | 958 Thousand | 7.72 Million | 1.21 Million | - | - |
| Cost of Revenue | 1.09 Million | 976 Thousand | 7.53 Million | 1.85 Million | 344 Thousand | 559 Thousand |
| Gross Profit | 413 Thousand | -18 Thousand | 188 Thousand | -639 Thousand | -344 Thousand | -559 Thousand |
| Operating Expenses | 25.63 Million | 30.31 Million | 47.13 Million | 33.08 Million | 22.23 Million | 15.2 Million |
| Selling, General and Administrative Expenses | 13.53 Million | 23.01 Million | 33.5 Million | 23.28 Million | 15.44 Million | 8.68 Million |
| Research and Development Expenses | 9.29 Million | 7.3 Million | 13.63 Million | 9.8 Million | 6.79 Million | 6.51 Million |
| Other Expenses | 2.71 Million | -67 Thousand | -37 Thousand | 27 Thousand | -3000.00 | 91 Thousand |
| Cost and Expenses | 26.63 Million | 31.29 Million | 54.67 Million | 34.93 Million | 22.23 Million | 15.2 Million |
| Operating Income | -25.13 Million | -17.99 Million | -46.94 Million | -29.71 Million | -22.23 Million | -15.2 Million |
| Interest Expense | 52 Thousand | 77 Thousand | 209 Thousand | 252 Thousand | 299 Thousand | 216 Thousand |
| Income Tax Expense | - | 54.82 Million | -9.26 Million | -1.25 Million | -97 Thousand | -336 Thousand |
| Earnings before Tax | -24.85 Million | -18.61 Million | -73.35 Million | -31.18 Million | -22.42 Million | -15.75 Million |
| Net Income | -27.78 Million | -73.44 Million | -64.09 Million | -29.93 Million | -22.32 Million | -15.75 Million |
| Earnings Per Share Basic | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 |
| Earnings Per Share Diluted | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 |
| Weighted Average Shares Outstanding | 7.65 Million | 5.54 Million | 4.44 Million | 3.27 Million | 2.56 Million | 1.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.65 Million | 5.54 Million | 4.44 Million | 3.27 Million | 2.56 Million | 1.89 Million |
| Gross Margin | 0.27 | -0.02 | 0.02 | -0.53 | - | - |
| EBIT Margin | -15.38 | -31.73 | -2.18 | -29.71 | - | - |
| Profit Margin | -18.48 | -76.66 | -8.30 | -24.62 | - | - |
| EBITDA | -23.12 Million | -13.31 Million | -48.45 Million | -30.54 Million | -21.89 Million | -15.2 Million |
| Earnings Before Tax Margin | -16.72 | -18.79 | -6.08 | -24.43 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 104 Thousand | 176 Thousand | 314 Thousand | 1.5 Million | 429 Thousand | 463 Thousand |
| Cost of Revenue | 334.5 Thousand | 511 Thousand | 409 Thousand | 1 Million | 181 Thousand | 191 Thousand |
| Gross Profit | -230.5 Thousand | -335 Thousand | -95 Thousand | 501 Thousand | 248 Thousand | 272 Thousand |
| Operating Expenses | 5.43 Million | 5.45 Million | 4.9 Million | 23.35 Million | 5.38 Million | 6.27 Million |
| Selling, General and Administrative Expenses | 3.21 Million | 3.51 Million | 2.33 Million | - | 3.2 Million | 3.85 Million |
| Research and Development Expenses | 2.21 Million | 1.93 Million | 2.54 Million | - | 2.18 Million | 2.43 Million |
| Other Expenses | 110 Thousand | 153 Thousand | -22 Thousand | -88 Thousand | -4000.00 | -16 Thousand |
| Cost and Expenses | 5.76 Million | 5.96 Million | 5.31 Million | 24.36 Million | 5.56 Million | 6.46 Million |
| Operating Income | -5.66 Million | -5.78 Million | -4.99 Million | -22.85 Million | -6.51 Million | -8.29 Million |
| Interest Expense | 8000.00 | 15 Thousand | 160 Thousand | 52 Thousand | 117 Thousand | 1000.00 |
| Income Tax Expense | - | - | 8.75 Million | 2.92 Million | 922 Thousand | 4.91 Million |
| Earnings before Tax | -4.53 Million | -9.12 Million | -15.99 Million | -24.85 Million | -6.48 Million | -8.33 Million |
| Net Income | -4.53 Million | -9.12 Million | -15.99 Million | -27.78 Million | -6.48 Million | -8.33 Million |
| Earnings Per Share Basic | -0.35 | -1.10 | -1.94 | - | -0.79 | -20.60 |
| Earnings Per Share Diluted | -0.35 | -1.10 | -1.94 | - | -0.79 | -20.60 |
| Weighted Average Shares Outstanding | 12.87 Million | 8.26 Million | 8.26 Million | 7.65 Million | 8.25 Million | 404.5 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 12.87 Million | 8.26 Million | 8.26 Million | 7.65 Million | 8.25 Million | 404.5 Thousand |
| Gross Margin | -2.22 | -1.90 | -0.30 | 0.33 | 0.58 | 0.59 |
| EBIT Margin | -51.32 | -30.97 | 12.98 | - | -8.56 | -7.04 |
| Profit Margin | -43.56 | -51.87 | -50.93 | -18.48 | -15.13 | -18.00 |
| EBITDA | -5.33 Million | -5.45 Million | 4.07 Million | - | -3.67 Million | -3.26 Million |
| Earnings Before Tax Margin | -54.45 | -32.88 | -15.92 | -15.21 | -15.18 | -17.91 |
0JTQ
0Y5X
LINDEINDIA
3485
OKYO
FAS